TABLE 2.
Primers used in this study
Restriction sites are underlined.
| No. | Sequence |
|---|---|
| 1 | TGTTGGATCCCTGGAGGGACTGCGGTC |
| 2 | CTAAGAATTCGAGATACGCCTGCTTGAG |
| 3 | TATCAAGCTTGACGAAGACGAAGGTGAG |
| 4 | TACTAGATCTCGAGCTCATGACGCCCAG |
| 5 | TACTAAGCTTCTGTTCGCGTACCACAC |
| 6 | TACTGGATCCGGCGGAGTCCTGGCTC |
| 7 | TACTGGATCCCAGCGGAGTGCCCCGTAG |
| 8 | TACTGAATTCCGTCATGGAACACCAGC |
| 9 | ACTTCAAGCTTGATGCCGTTGGTGGACCC |
| 10 | ACTTAGGATCCAGCCTGCTTCGCCATTTC |
| 11 | ACTTAGGATCCGCTGCCTGATCCTCGACC |
| 12 | ACTTAGAATTCCTCCTCGGCACGCTGTTC |
| 13 | ACTTAGGATCCACGACGAGAACGCGCAC |
| 14 | TACTAAGCTTGCAGCAGGAAGAGCCGCT |
| 15 | ACTTAGGATCCTGTCTCGGCGAAGAGAGTC |
| 16 | TACTAAGCTTCTACGGGGCACTCCGCTG |
| 17 | TACTAGATCTGAAACAACGGATGTGAATC |
| 18 | TACTAAGCTTGAGGTGGACTTCATCGTTC |
| 19 | GGATCCCCTCCCCACCACCTGC |
| 20 | GGATCCGGCAGGCACTCCCCCTCC |
| 21 | GGATCCGGAGCCGAGGCGTCCTG |
| 22 | GGATCCCCGCCGACGACGAGAAC |
| 23 | FAM-GCCAGGGTTTTCCCAGTCACGA |
| 24 | TACTGGATCCGTGGGTGCGCTGGGCGTC |
| 25 | TACTAAGCTTCGCCGGCCGTGACCGCAG |
| 26 | AATAGGATCCATGAGCCAGGACTCCGCC |
| 27 | TACTAAGCTTCTACGGGGCACTCCGCTG |
| 28 | Biotin-GCCAGGGTTTTCCCAGTCACGA |
| 29 | GAGCGGATAACAATTTCACACAGG |